[Featured Stock] Oncocross Soars Over 70% on First Day of KOSDAQ Listing

Oncocross, an artificial intelligence (AI)-based new drug development company, is showing strong performance on its first day listed on the KOSDAQ market.

As of 10:09 a.m. on the 18th, Oncocross is trading at 12,460 KRW, up 70.82% from the public offering price of 7,300 KRW.

Oncocross provides a service that discovers optimal indications (treatment scopes) for new drug candidates or already developed drugs through its self-developed AI platform, 'Raptor AI.'

From the demand forecast conducted for institutional investors from the 27th of last month to the 3rd, the public offering price was set at 7,300 KRW, which is lower than the lower end of the desired range (10,100 to 12,300 KRW).

In the subsequent general subscription, a competition rate of 1,313 to 1 was recorded, and subscription deposits amounted to 1.7048 trillion KRW.